Letter to the Editor: The treatment options for de novo perihilar cholangiocarcinoma require more details. Zeng Q, Xie D, Zhou Q, Qian B, et al. Hepatology 2025 Aug 13. doi: 10.1097/HEP.0000000000001496.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeng Q, Xie D, Zhou Q, Qian B, et al. Letter to the Editor: The treatment options for de novo perihilar cholangiocarcinoma require more details. Hepatology 2025 Aug 13. doi: 10.1097/HEP.0000000000001496.
PMID: 40802891